gsk2618960
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 13, 2013 (NCT01808482)
Timeline
Indications
Mechanism of action
- Interleukin-7INHIBITOR
Interleukin-7 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068502 ↗
Also known as
- gsk2618960
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03239600 | Phase 2 | Sep 19, 2017 | GlaxoSmithKline |
| NCT02293161 | Phase 1 | Nov 11, 2014 | GlaxoSmithKline |
| NCT01808482 | Phase 1 | Mar 13, 2013 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 3 | 3 | 2 | 2013 |
1 organizations
Page 1 / 1